Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Gemfibrozil in Carotid Atherosclerosis
NCT00243672Phase 4Withdrawn
- Sponsor
- Universitätsklinikum Münster
- Start
- Oct 2005
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of atorvastatin, gemfibrozil in atherosclerosis, sponsored by Universitätsklinikum Münster. Planned start Oct 2005; status: withdrawn.
02
Drugs
atorvastatingemfibrozil
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00243672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243672.